A Randomized Double-Blind and Placebo-Controlled Study to the Influence of Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Patients With Mild to Moderate Atopic Asthma (House Dust Mite).
Withdrawn prior to enrolment
Phase of Trial: Phase II/III
Latest Information Update: 13 Apr 2012
At a glance
- Drugs Montelukast (Primary) ; Ramatroban (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Apr 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 17 Nov 2006 New trial record.